Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

POLL VOTING RESULT OF EXTRAORDINARY GENERAL MEETING HELD ON 21 FEBRUARY 2013

China Pharmaceutical Group Limited (the "Company") is pleased to announce the poll voting result in respect of the resolution proposed at the extraordinary general meeting (the "EGM") of the Company held on 21 February 2013 as follows:

SPECIAL RESOLUTION

Number of Votes (%)

SPECIAL RESOLUTION

For

Against

To approve the proposed change of name of the Company as set out in the notice convening the EGM.

2,051,234,810 (99.997%)

70,000 (0.003%)

As more than 75% of the votes were cast in favour of this special resolution, the resolution was duly passed.

As at the date of the EGM, the total number of issued shares of the Company was 2,725,421,698 shares, which was the total number of shares entitling the holders to attend and vote for or against the resolution at the EGM. There were no shares entitling the holders to attend and abstain from voting in favour of the resolution at the EGM as set out in Rule 13.40 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and there were no shareholders that were required to abstain from voting at the EGM under the Listing Rules.
Tricor Secretaries Limited, the Hong Kong Share Registrar of the Company, acted as scrutineer for the poll at the EGM.
Shareholders may refer to the circular dated 23 January 2013 for details of the above resolution proposed at the EGM. The proposed change of name will become effective subject to the issuance of the certificate of incorporation on change of name by the Registrar of Companies in Hong Kong and a further announcement will be made by the Company upon the proposed change of name becoming effective.
By order of the board

China Pharmaceutical Group Limited

CAI Dongchen

Chairman

Hong Kong, 21 February 2013

As at the date of this announcement, the board of directors of the Company comprises Mr. Cai Dongchen, Mr. Feng Zhenying, Mr. Chak Kin Man, Mr. Pan Weidong, Mr. Zhao John Huan, Mr. Wang Shunlong, Mr. Wang Huaiyu, Mr. Lu Jianmin and Mr. Wang Zhenguo as executive directors; Mr. Lee Ka Sze, Carmelo as non-executive director and Mr. Huo Zhenxing, Mr. Qi Moujia, Mr. Guo Shichang, Mr. Chan Siu Keung, Leonard, Mr. Wang Bo and Mr. Zhang Fawang as independent non-executive directors.

distributed by